Literature DB >> 27733673

Vaccination practices in patients with inflammatory bowel disease among general internal medicine physicians in the USA.

Grigoriy E Gurvits1, Gloria Lan2, Amy Tan3, Arlene Weissman4.   

Abstract

BACKGROUND: Increasing prevalence of inflammatory bowel disease (IBD) poses significant challenges to medical community. Preventive medicine, including vaccination against opportunistic infections, is important in decreasing morbidity and mortality in patients with IBD. We conduct first study to evaluate general awareness and adherence to immunisation guidelines by primary care physicians in the USA.
METHODS: We administered an electronic questionnaire to the research panel of the American College of Physicians (ACP) assessing current vaccination practices, barriers to vaccination and provider responsibility for administering vaccinations and compared responses with the European Crohn's and Colitis Organization consensus guidelines and expert opinion from the USA.
RESULTS: All of surveyed physicians (276) had experience with patients with IBD and spent majority of their time in direct patient care. 49% of physicians took immunisation history frequently or always, and 76% reported never or rarely checking immunisation antibody titres with only 2% doing so routinely. 65% of physicians believed that primary care providers (PCPs) were responsible for determining patient's immunisation. Vaccine administration was felt to be the duty of primary care doctor 80% of the time. 2.5% of physicians correctly recommended vaccinations all the time. Physicians were more likely to recommend vaccination to immunocompetent than immunocompromised patients. Up to 23% of physicians would incorrectly recommend live vaccine to immunocompromised patients with IBD.
CONCLUSIONS: Current knowledge and degree of comfort among PCPs in the USA in preventing opportunistic infections in IBD population remain low. Management of patients with IBD requires structured approach to their healthcare maintenance in everyday practice, including enhanced educational policy aimed at primary care physicians. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Crohn’s disease; PRIMARY CARE; immunodeficiency; ulcerative colitis; vaccination

Mesh:

Year:  2016        PMID: 27733673     DOI: 10.1136/postgradmedj-2016-134266

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  7 in total

1.  Lax Prophylaxis: Vaccinating the Inflammatory Bowel Disease Patient.

Authors:  Grigoriy E Gurvits
Journal:  Dig Dis Sci       Date:  2018-01       Impact factor: 3.199

2.  Vaccination of Patients With Inflammatory Bowel Disease.

Authors:  Francis A Farraye
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-07

3.  Receipt of Preventive Care Services Among US Adults with Inflammatory Bowel Disease, 2015-2016.

Authors:  Fang Xu; James M Dahlhamer; Emily P Terlizzi; Anne G Wheaton; Janet B Croft
Journal:  Dig Dis Sci       Date:  2019-02-12       Impact factor: 3.487

Review 4.  Vaccination in Patients with Inflammatory Bowel Diseases.

Authors:  Christine N Manser; Michel H Maillard; Gerhard Rogler; Philipp Schreiner; Florian Rieder; Silja Bühler
Journal:  Digestion       Date:  2020-01-22       Impact factor: 3.216

5.  Immunisation status of children and adolescents with a new diagnosis of inflammatory bowel disease.

Authors:  Timothy Ford; Margie Danchin; Alissa McMinn; Kirsten Perrett; George Alex; Nigel W Crawford
Journal:  BMC Infect Dis       Date:  2022-01-04       Impact factor: 3.090

Review 6.  Update on Vaccinating the Patient With Inflammatory Bowel Disease.

Authors:  Jennifer Coukos; Francis A Farraye
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

7.  Vaccination status of patients using anti-TNF therapy and the physicians' behavior shaping the phenomenon: Mixed-methods approach.

Authors:  Hussain Abdulrahman Al-Omar; Hadeel Magdy Sherif; Ahmed Yaccob Mayet
Journal:  PLoS One       Date:  2019-10-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.